Results 201 to 210 of about 2,306,483 (343)
To overcome pancreatic cancer's immunosuppressive barriers, this study explores a dual approach: triggering immunogenic tumor cell death at the primary tumor site with irinotecan‐loaded silicasomes and enhancing immune activation in the spleen using LNPs encapsulating tumor antigen mRNA and a TLR7/8 agonist.
Lijia Luo+3 more
wiley +1 more source
Is it now possible to transition from laparoscopic liver resection to robotic liver resection? [PDF]
Kim KS, Jun DW.
europepmc +1 more source
Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant Chemotherapy
Henry Bismuth+7 more
openalex +2 more sources
This study employs neutrophils for the precise delivery of anti‐CD47 antibodies, combined with bacterial outer membrane vesicles, to enhance macrophage phagocytic function in the tumor microenvironment. This approach effectively activates T‐cell anti‐tumor immune responses and significantly reduces the risk of postoperative tumor recurrence and ...
Meng Guan+15 more
wiley +1 more source
Robotic liver resection for hepatocellular carcinoma: a new dawn? [PDF]
Chong CC.
europepmc +1 more source
Continuous Versus Intermittent Portal Triad Clamping for Liver Resection
Jacques Belghiti+7 more
openalex +2 more sources
The Role of CAF‐derived Vitronectin in Promoting Colorectal Cancer Progression and Immunosuppression
Cancer‐associated fibroblast (CAF)‐derived VTN upregulates SLC6A8 expression in colorectal cancer (CRC) cells and macrophages through enhanced FAK phosphorylation. This modulation significantly increases the cellular uptake of creatine and ATP, promoting cancer progression and macrophage polarization.
Jiahua Yu+5 more
wiley +1 more source
Not all reoperative laparoscopic liver resection procedures are feasible for hepatolithiasis patients with a history of biliary surgery. [PDF]
Zhang WJ, Chen G, Dai DF, Chen XP.
europepmc +1 more source